Hutch News
Results per Page:
Being your own caregiver during cancer
Friends, siblings, support groups and social media can all make a huge difference for patients ‘cancering’ on their own
New therapeutic strategy turns a cancer’s advantage into its downfall
In the lab, researchers use synthetic mRNA to trick tumors into manufacturing cancer-specific poison
Selective stimulation of neoantigen-specific T cells by immunotherapy
From the Riddell Lab, Clinical Research Division
Kent police officer takes charge of his toughest case yet
Garth's eye problems ended up being ocular melanoma.
Public health throws shade on tanning, and it works
New study shows sharp drop in melanoma rates in people under 30, but skin cancer rates still going up in those over 40
Nanotech turns pro-tumor immune cells into cancer-killing triple agents
Strategy doubles survival in mice with cancer
Seattle mayor and melanoma survivor Jenny Durkan visits Fred Hutch
Mayor shares personal story as Hutch scientists outline the future of cancer therapy
5 tips for a healthy summer
From bench to beachside: Empower yourself with evidenced-based cancer-prevention science
His immune system eradicated his melanoma. Could other patients’ bodies be taught to do the same thing?
How one man’s T cells are guiding the development of next-gen immunotherapies
Green means go: receipt of macrophage cytoplasm by tumor cells correlates with migratory behavior
From the Moens Lab, Basic Sciences Division
Immune cells share their insides with tumors to promote cancer spread
New study in zebrafish and mice shows immune cells interact with melanoma and transfer their contents to spur metastasis
7 skin cancer myths — debunked
Experts take on base tans and other ‘complete baloney’ standing in the way of skin health
Forum at Fred Hutch focuses on the hottest developments in cancer immunotherapy
Immune-based treatments move from the fringes to the spotlight